drugset / Trial / NCT07432997

Pharmacological Enhancement of Glymphatic Function in Humans

NCT07432997

Non-randomizedCrossoverDouble-blindTreatment

Summary

Alzheimer's disease is linked in part to the buildup of harmful proteins in the brain, including amyloid and tau. Most current treatments aim to remove these proteins directly. This study explores a different approach: helping the brain clear waste more effectively during sleep. The investigators will test whether certain medications can safely boost the brain's natural "cleaning system," known as the glymphatic system, in healthy older adults. Participants will receive controlled sleep treatments and blood tests to measure protein clearance. If successful, this strategy could support new therapies that work alongside existing Alzheimer's treatments.

Timeline

Start
2023-12-11
Primary completion
2024-09-13
Completion
2024-09-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified
Comparator Midodrine Small molecule

Indications